Bernward Schölkens

Title: Bernward Schölkens: Innovator in Cardiovascular Medicine

Introduction

Bernward Schölkens is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of cardiovascular medicine through his innovative research and patenting efforts. His work focuses on the use of inhibitors of the renin-angiotensin system, which play a crucial role in preventing cardiovascular events.

Latest Patents

Bernward Schölkens holds a patent titled "Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events." This patent outlines the use of an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative, optionally combined with other antihypertensives, cholesterol-lowering agents, diuretics, or aspirin. The patent describes a method for preventing cardiovascular events by administering an effective amount of these inhibitors to patients in need. This innovative approach has the potential to significantly impact patient care in cardiovascular health.

Career Highlights

Schölkens is associated with Sanofi-Aventis Deutschland GmbH, where he continues to contribute to advancements in medical science. His work has been instrumental in developing new therapeutic strategies for managing cardiovascular diseases.

Collaborations

Throughout his career, Bernward Schölkens has collaborated with esteemed colleagues, including Norbert Bender and Badrudin Rangoonwala. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical industry.

Conclusion

Bernward Schölkens is a distinguished inventor whose work in cardiovascular medicine has led to important advancements in treatment options. His patent on the use of inhibitors of the renin-angiotensin system exemplifies his commitment to improving patient outcomes. His contributions continue to influence the field and inspire future innovations.